1. Home
  2. STX vs RMD Comparison

STX vs RMD Comparison

Compare STX & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STX
  • RMD
  • Stock Information
  • Founded
  • STX 1978
  • RMD 1989
  • Country
  • STX Singapore
  • RMD United States
  • Employees
  • STX N/A
  • RMD N/A
  • Industry
  • STX Electronic Components
  • RMD Medical/Dental Instruments
  • Sector
  • STX Technology
  • RMD Health Care
  • Exchange
  • STX Nasdaq
  • RMD Nasdaq
  • Market Cap
  • STX 46.3B
  • RMD 40.7B
  • IPO Year
  • STX 2002
  • RMD 1995
  • Fundamental
  • Price
  • STX $224.59
  • RMD $282.71
  • Analyst Decision
  • STX Buy
  • RMD Buy
  • Analyst Count
  • STX 20
  • RMD 11
  • Target Price
  • STX $184.05
  • RMD $288.89
  • AVG Volume (30 Days)
  • STX 5.0M
  • RMD 895.5K
  • Earning Date
  • STX 10-29-2025
  • RMD 10-23-2025
  • Dividend Yield
  • STX 1.28%
  • RMD 0.85%
  • EPS Growth
  • STX 328.48
  • RMD 37.43
  • EPS
  • STX 6.77
  • RMD 9.51
  • Revenue
  • STX $9,097,000,000.00
  • RMD $5,146,327,000.00
  • Revenue This Year
  • STX $16.54
  • RMD $9.69
  • Revenue Next Year
  • STX $9.96
  • RMD $7.26
  • P/E Ratio
  • STX $33.13
  • RMD $29.78
  • Revenue Growth
  • STX 38.86
  • RMD 9.84
  • 52 Week Low
  • STX $63.19
  • RMD $199.92
  • 52 Week High
  • STX $264.83
  • RMD $293.81
  • Technical
  • Relative Strength Index (RSI)
  • STX 57.92
  • RMD 59.62
  • Support Level
  • STX $223.01
  • RMD $267.64
  • Resistance Level
  • STX $264.83
  • RMD $277.43
  • Average True Range (ATR)
  • STX 11.05
  • RMD 4.70
  • MACD
  • STX -1.93
  • RMD 1.42
  • Stochastic Oscillator
  • STX 26.38
  • RMD 88.57

About STX Seagate Technology Holdings PLC (Ireland)

Seagate Technology is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: